HK Stock Market Move | UBTECH ROBOTICS (09880) rose more than 5% in early trading. The company has reached a cooperation agreement with Siasun Robot & Automation to deploy 10,000 units of humanoid robots within 5 years.
UBH (09880) rose more than 5% in early trading, as of the time of writing, it rose by 3.75% to HK$113.4, with a turnover of HK$7.1 billion.
UBTECH ROBOTICS (09880) rose by over 5% in early trading. As of the time of writing, it has risen by 3.75% to 113.4 Hong Kong dollars, with a turnover of 7.1 billion Hong Kong dollars.
In terms of news, on December 2nd, UBTECH ROBOTICS announced that it had recently signed a strategic cooperation framework agreement with Zuoye Technology. The two parties will focus on the core direction of "industry model + embodied intelligence" and plan to deploy 10,000 units of Siasun Robot & Automation within the next 5 years. They will also collaborate to expand commercial orders totaling tens of billions and jointly promote the application of large-scale industry models + humanoid Siasun Robot & Automation solutions in multiple fields.
It is worth noting that on November 28th, UBTECH ROBOTICS won the bid for the data collection and training center project for humanoid Siasun Robot & Automation in Jiujiang City, Jiangxi. The bid amount is 143 million yuan. This project will utilize UBTECH ROBOTICS' latest industrial humanoid Siasun Robot & Automation Walker S2, which can autonomously replace batteries. As of now, the total value of orders for UBTECH ROBOTICS' Walker series humanoid Siasun Robot & Automation in 2025 has reached 1.3 billion yuan.
Related Articles

MNSO (09896) spent $248,300 to repurchase 51,300 shares on December 3rd.

GEELY AUTO (00175) issued 62,500 shares due to the exercise of subscription rights.

Breakthrough! Sinopharm's first export to Macau - quadrivalent influenza subunit vaccine supports health protection in Macau region.
MNSO (09896) spent $248,300 to repurchase 51,300 shares on December 3rd.

GEELY AUTO (00175) issued 62,500 shares due to the exercise of subscription rights.

Breakthrough! Sinopharm's first export to Macau - quadrivalent influenza subunit vaccine supports health protection in Macau region.






